Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Kexing Biopharm Co Ltd
SSE:688136
Kexing Biopharm Co Ltd
SSE:688136
Price:
23.27
CNY
-5.37%
Market Cap:
¥4.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Kexing Biopharm Co Ltd
SSE:688136
|
CN |
|
D
|
Dollar Tree Inc
BMV:DLTR
|
US |
|
Orient Semiconductor Electronics Ltd
TWSE:2329
|
TW |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Kexing Biopharm Co Ltd's stock price target?
Not Available
Kexing Biopharm Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Kexing Biopharm Co Ltd?
Projected CAGR
13%
13%
Over the last 7 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Kexing Biopharm Co Ltd?
Projected CAGR
52%
52%
Over the last 7 years, the compound annual growth rate for Operating Income has been -5%. The projected CAGR for the next 3 years is 52%.
What is the Pre-Tax Income forecast for Kexing Biopharm Co Ltd?
Projected CAGR
23%
23%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 23%.
What is the Net Income forecast for Kexing Biopharm Co Ltd?
Projected CAGR
21%
21%
Over the last 7 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 21%.